Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Karyopharm Therapeutics Inc. (KPTI)  
$1.08 0.00 (0.00%) as of 4:30 Wed 5/1


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 113,340,000
Market Cap: 122.41(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6758 - $2.77
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Karyopharm Therapeutics is a pharmaceutical company focused on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Co.'s main asset, XPOVIO® (selinexor), a Selective Inhibitors of Nuclear Export compound, is indicated for use in adult patients with multiple myeloma who have received at least one prior therapy; adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 41,140 41,140
Total Buy Value $0 $0 $49,985 $49,985
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 255,827 267,169 312,512 975,987
Total Sell Value $306,355 $315,908 $393,256 $4,268,294
Total People Sold 6 6 6 8
Total Sell Transactions 19 22 34 58
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 592
  Page 5 of 24  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kauffman Michael Director   –       •      –    2022-02-17 4 S $12.12 $110,177 I/I (9,088) 904,357 62%     
   Kauffman Michael Director   –       •      –    2022-02-17 4 S $12.12 $110,068 D/D (9,079) 698,983 62%     
   Frenkel Ran EVP, Chief Dev. Officer   •       –      –    2022-02-17 4 S $12.12 $35,509 D/D (2,929) 101,703 62%     
   Shacham Sharon Chief Scientific Officer   •       –      –    2022-02-17 4 S $12.12 $110,068 I/I (9,079) 698,983 62%     
   Shacham Sharon Chief Scientific Officer   •       –      –    2022-02-17 4 S $12.12 $110,177 D/D (9,088) 904,357 62%     
   Shah Jatin EVP, Chief Medical Officer   •       –      –    2022-02-17 4 S $12.12 $15,833 D/D (1,306) 129,450 62%     
   Shacham Sharon Chief Scientific Officer   •       –      –    2022-02-07 4 S $9.86 $66,707 I/I (6,764) 708,062 59%     
   Shacham Sharon Chief Scientific Officer   •       –      –    2022-02-07 4 S $9.86 $66,144 D/D (6,707) 913,445 59%     
   Shah Jatin EVP, Chief Medical Officer   •       –      –    2022-02-07 4 S $9.86 $16,805 D/D (1,704) 130,756 59%     
   Mason Michael EVP, CFO & Treasurer   •       –      –    2022-02-07 4 S $9.86 $38,925 D/D (3,947) 53,308 59%     
   Kauffman Michael Director   –       •      –    2022-02-07 4 S $9.86 $66,144 I/I (6,707) 913,445 59%     
   Kauffman Michael Director   –       •      –    2022-02-07 4 S $9.86 $66,707 D/D (6,764) 708,062 59%     
   Frenkel Ran EVP, Chief Dev. Officer   •       –      –    2022-02-07 4 S $9.86 $19,635 D/D (1,991) 104,632 59%     
   Mitchener Stephen SVP, Chief Business Officer   •       –      –    2021-12-02 4 S $6.69 $3,338 D/D (499) 3,296 -16%     
   Shah Jatin EVP, Chief Medical Officer   •       –      –    2021-07-12 4 D $9.73 $6,470 D/D (665) 131,137     -
   Cheng Sohanya Roshan SVP Sales & Commercial Ops   •       –      –    2021-06-30 4 A $0.00 $0 D/D 7,500 7,500     -
   Mitchener Stephen SVP, Chief Business Officer   •       –      –    2021-06-02 4 S $9.29 $4,905 D/D (528) 2,472 38%     
   Mason Michael EVP, CFO, Treasurer   •       –      –    2021-06-01 4 A $0.00 $0 D/D 5,500 57,255     -
   Mitchener Stephen SVP, Chief Business Officer   •       –      –    2021-05-30 4 OE $0.00 $0 D/D 1,500 3,000     -
   Shah Jatin EVP, Chief Medical Officer   •       –      –    2021-05-07 4 B $8.60 $199,992 D/D 23,250 131,802 2.74 -31%     
   Bohlin Garen G Director   –       •      –    2021-05-06 4 B $7.82 $31,280 D/D 4,000 4,000 2.39 -30%     
   Paulson Richard A. President and CEO   •       •      –    2021-05-03 4 A $0.00 $0 D/D 373,200 373,200     -
   Kauffman Michael Chief Executive Officer   •       •      –    2021-03-18 4 AS $12.39 $49,553 D/D (4,000) 714,826 -27%     
   Shacham Sharon President & CSO   •       –      –    2021-03-18 4 AS $12.39 $49,553 I/I (4,000) 714,826 -27%     
   Shah Jatin EVP, Chief Medical Officer   •       –      –    2021-02-25 4 A $0.00 $0 D/D 22,013 107,691     -
  592 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 24
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us